It is our study that collects LRRN4CL, HS3ST3A1, PCOLCE2, and CAPN8 all together for the first time and sets them as biomarkers related to TME in thyroid cancer, which might become potential candidate targets for TC immunotherapy. The gene discussed is LRRN4CL; the disease is thyroid gland carcinoma.